insights_auto
Why is SABS down ၇.၅၅%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
၂.၉၄ US$
arrow_downward
-၇.၅၅%(-၀.၂၄) 1D
၂.၉၄ US$
၀.၀၀% (၀.၀၀)
bedtimeAfter hours
Closed: နို ၅, GMT-၅ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
၃.၂၄ US$
High
၃.၂၄ US$
Low
၂.၉၁ US$
Mkt. cap
၂၆.၇၅ ကုဋေ
Avg. vol.
၇.၂၂ သိန်း
Volume
၂.၉၃ သိန်း
52-wk high
၅.၁၅ US$
52-wk low
၂.၄၄ US$
EPS
-၀.၆၃ US$
Beta
၀.၆၇
Shares outstanding
၉.၁၀ ကုဋေ
No. of employees
၈၆
Open
၃.၂၄ US$
High
၃.၂၄ US$
Low
၂.၉၁ US$
Mkt. cap
၂၆.၇၅ ကုဋေ
Avg. vol.
၇.၂၂ သိန်း
Volume
၂.၉၃ သိန်း
52-wk high
၅.၁၅ US$
52-wk low
၂.၄၄ US$
EPS
-၀.၆၃ US$
Beta
၀.၆၇
Shares outstanding
၉.၁၀ ကုဋေ
No. of employees
၈၆
News stories
From web sources and news partners
Yahoo Finance
·
ပြီးခဲ့သည့် ၅ နာရီ
SAB Biotherapeutics Inc (SABS) (Q3 2026) Earnings Call Highlights: FDA Fast-Track Win, Full ...
TradingView
·
ပြီးခဲ့သည့် ၈ နာရီ
SAB Biotherapeutics, Inc. reports results for the quarter ended September 30 - Earnings Summary
Benzinga
·
ပြီးခဲ့သည့် ၁၄ နာရီ
SAB Biotherapeutics Q3 2026 Earnings Call Transcript
The Manila Times
·
ပြီးခဲ့သည့် ၁၆ နာရီ
SAB BIO Reports Q3 2026 Financial Results and Provides Business Highlights
About SAB Biotherapeutics Inc
CEO-
Employees၈၆
Founded၂၀၁၄
HeadquartersMiami Beach, ဖလော်ရီဒါပြည်နယ်, ယူနိုက်တက်စတိတ်
SectorHealth Care
Industry-
Websitesab.bio